Request for Information on the FY 2013-2018 Strategic Plan for the Office of Disease Prevention, 15960-15961 [2013-05773]
Download as PDF
<![CDATA[
15960
Federal Register / Vol. 78, No. 49 / Wednesday, March 13, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
time per
response
(in hours)
Total annual
burden hour
Applicants ........................................................................................................
1,560
1
25/60
650
Dated: February 1, 2013.
Timothy J. Tosten,
Executive Officer, Deputy Ethics Counselor,
Director, Division of Management Services,
Center for Scientific Review, NIH.
[FR Doc. 2013–05776 Filed 3–12–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on the FY
2013–2018 Strategic Plan for the Office
of Disease Prevention
The purpose of this Request
for Information (RFI) is to seek broad
public input on the Fiscal Year (FY)
2013–2018 Strategic Plan for the Office
of Disease Prevention (ODP), National
Institutes of Health (NIH).
DATES: To ensure consideration,
responses must be received by April 14,
2013.
ADDRESSES: Comments must be
submitted electronically using the webbased form available at https://
prevention.nih.gov/aboutus/
strategic_plan/rfi.aspx.
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to Wilma
Peterman Cross, M.S.; Senior Public
Health Advisor, Office of Disease
Prevention, National Institutes of
Health; phone: 301–496–1508; email:
prevention@mail.nih.gov.
SUMMARY:
The
mission of ODP is to improve the public
health by increasing the scope, quality,
dissemination, and impact of prevention
research supported by the NIH. ODP
will fulfill this mission by providing
leadership for the development,
coordination, and implementation of
prevention research in collaboration
with the NIH Institutes and Centers (ICs)
and other partners. The Office is
responsible for advising the Director,
NIH, regarding prevention research
issues, actions, and activities. The
Office also provides overall guidance to
the ICs on biomedical programs that
seek to improve the nation’s health
through research, training, knowledge
translation, and public education as
mstockstill on DSK4VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
17:11 Mar 12, 2013
Jkt 229001
they relate to health promotion and
disease prevention.
Prevention research at the NIH
encompasses research designed both to
promote health and to prevent the onset
of disease, disorders, or injuries and the
progression of asymptomatic disease.
Prevention research targets biology and
genetics, individual behavior, factors in
the social and physical environments,
and health services; and it informs and
evaluates health-related policies and
regulations. Prevention research
includes:
• Identification and assessment of
risk and protective factors.
• Screening and identification of
individuals and groups at risk.
• Development and evaluation of
interventions to reduce risk.
• Translation and dissemination of
effective preventive interventions into
practice.
• Development of research methods
to support this work.
The Office was established in 1986 in
response to a directive in the Health
Research Extension Act of 1985. With
increased attention on the application of
prevention research nationally and the
recent reorganization of ODP, the Office
has embarked on an extensive planning
process to develop a strategic plan for
FY 2013–2018.
Information Requested
This RFI is intended to gather broad
public input on the strategic priorities to
be included in the plan and other
suggestions on how to enhance the
prevention research portfolio at the NIH.
The ODP invites input from prevention
researchers in academia and industry;
from health care professionals, patient
advocates and advocacy organizations,
scientific or professional organizations,
federal agencies; and from other
interested members of the public.
Organizations are strongly encouraged
to submit a single response that reflects
the views of their organization and
membership as a whole.
Your perspectives can include, but are
not limited to, the following topics as
they relate to the six draft strategic
priorities listed below:
• Suggested changes, additions, or
deletions to the list of strategic priorities
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
• Recommended measurable
objectives associated with an individual
priority
• Appropriate benchmarks for
gauging progress toward each
recommended objective.
Strategic Priority #1: Systematically
monitor NIH investments in prevention
research and the progress and results of
that research.
Strategic Priority #2: Identify and
promote prevention research areas that
deserve expanded effort and investment
by the NIH.
Strategic Priority #3: Promote the use
of the best available methods in
prevention research and support the
development of new and innovative
approaches.
Strategic Priority #4: Encourage
development of collaborative prevention
research projects and facilitate
coordination of such projects across the
NIH and with other public and private
entities.
Strategic Priority #5: Identify and
promote the use of effective evidencebased interventions.
Strategic Priority #6: Increase the
visibility of prevention research at the
NIH and across the country.
In addition to the strategic priorities,
the ODP welcomes suggestions on how
to enhance the prevention research
portfolio at the NIH:
1. Suggested changes to the approach
used by the NIH to develop funding
opportunity announcements that could
improve the quality of prevention
research supported by the NIH.
2. Suggested changes to the approach
used by the NIH to review applications
that could improve the quality of
prevention research supported by the
NIH.
3. Suggested changes to the approach
used by the NIH in managing funded
projects that could improve the quality
of prevention research supported by the
NIH.
How To Submit a Response
To ensure consideration, responses
must be received by April 14, 2013, and
should be submitted electronically
using the web-based form available at
https://prevention.nih.gov/aboutus/
strategic_plan/rfi.aspx. The web form
will provide confirmation of response
E:\FR\FM\13MRN1.SGM
13MRN1
Federal Register / Vol. 78, No. 49 / Wednesday, March 13, 2013 / Notices
submission, but respondents will not
receive individualized feedback. All
respondents are encouraged to sign up
for the ODP email list at https://
prevention-nih.org/subscribe to receive
information related to Office activities,
including updates on the development
and release of the final strategic plan.
Responses to this RFI are voluntary and
may be submitted anonymously. Please
do not include any personally
identifiable or other information that
you do not wish to make public.
Proprietary, classified, confidential, or
sensitive information should not be
included in responses. Comments
submitted will be compiled for
discussion and incorporated into the
ODP strategic plan as appropriate. Any
personal identifiers (personal names,
email addresses, etc.) will be removed
when responses are compiled. This RFI
is for informational and planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the United States Government to
provide support for any ideas identified
in response to it. Please note that the
U.S. Government will not pay for the
preparation of any information
submitted or for use of that information.
Dated: February 5, 2013.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2013–05773 Filed 3–12–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Center for Substance Abuse Treatment
National Advisory Council; Meeting
Pursuant to Public Law 92–463,
notice is hereby given of the meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Treatment
National Advisory Council on April 10,
2013.
The meeting is open to the public and
will include a discussion of the Center’s
current administrative, legislative, and
program developments. Public
comments are welcome. To attend onsite, or request special accommodations
for persons with disabilities, please
register at SAMHSA Committees’ Web
site, https://nac.samhsa.gov/
Registration/meetingsRegistration.aspx,
or contact the Council’s Designated
Federal Officer, Ms. Cynthia Graham
(see contact information below).
VerDate Mar<15>2010
17:11 Mar 12, 2013
Jkt 229001
Committee Name: Substance Abuse and
Mental Health Services Administration
Center for Substance Abuse Treatment
National Advisory Council.
Date/Time/Type: April 10, 2013 9:00 a.m.–
4:30 p.m. (OPEN).
Place: SAMHSA, 1 Choke Cherry Road,
Sugarloaf Conference Room, Rockville, MD
20857.
Contact: Cynthia Graham, M.S., Designated
Federal Official, SAMHSA/CSAT National
Advisory Council, 1 Choke Cherry Road,
Room 5–1035, Rockville, MD 20857,
Telephone: (240) 276–1692, FAX: (240) 276–
1690, Email:
cynthia.graham@samhsa.hhs.gov.
Cathy J. Friedman,
Public Health Analyst, SAMHSA.
[FR Doc. 2013–05407 Filed 3–12–13; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
National Advisory Council; Notice of
Meeting
Pursuant to Public Law 92–463,
notice is hereby given of a meeting of
the Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
National Advisory Council (NAC) on
April 12, 2013.
The meeting will include a recap of
the April 11, 2013 Joint Council
meeting, and discussions of the National
Behavioral Health Quality Framework
and Barometer, National Dialogue, and
prescription drug abuse.
The meeting is open to the public and
will be held at the SAMHSA building,
1 Choke Cherry Road, Rockville, MD
20857 in the Sugarloaf Conference
Room. Attendance by the public will be
limited to space available. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the committee. Written
submissions should be forwarded to the
contact person on or before one week
prior to the meeting. Oral presentations
from the public will be scheduled at the
conclusion of the meeting. Individuals
interested in making oral presentations
are encouraged to notify the contact on
or before one week prior to the meeting.
Five minutes will be allotted for each
presentation.
The meeting may be accessed via
teleconference. To attend on site, obtain
the call-in number and access code,
submit written or brief oral comments,
or request special accommodations for
persons with disabilities, please register
on-line at https://nac.samhsa.gov/
Registration/meetingsRegistration.aspx,
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
15961
or communicate with SAMHSA’s
Committee Management Officer, Ms.
Geretta Wood (see contact information
below).
Substantive meeting information and
a roster of Committee members may be
obtained either by accessing the
SAMHSA Committees’ Web site at
https://nac.samhsa.gov/
WomenServices/index.aspx, or by
contacting Ms. Wood. The transcript for
the meeting will be available on the
SAMHSA Committees’ Web site within
three weeks after the meeting.
Committee Name: SAMHSA’s National
Advisory Council.
Date/Time/Type: Friday, April 12, 2013
from 9 a.m. to 3:30 EDT: OPEN.
Place: SAMHSA, 1 Choke Cherry Road,
SAMHSA Sugarloaf Conference Room,
Rockville, Maryland 20857.
Contact: Geretta Wood, Committee
Management Officer and Designated Federal
Official of the SAMHSA National Advisory
Council and SAMHSA’s Advisory Committee
for Women’s Services, 1 Choke Cherry Road,
Rockville, Maryland 20857, Telephone: (240)
276–2326, Fax: (240) 276–2252 and Email:
geretta.wood@samhsa.hhs.gov.
Cathy J. Friedman,
Public Health Analyst, SAMHSA.
[FR Doc. 2013–05757 Filed 3–12–13; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given of the combined
meeting on April 11, 2013, of the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
four National Advisory Councils (the
SAMHSA National Advisory Council
(NAC), the Center for Mental Health
Services NAC, the Center for Substance
Abuse Prevention NAC, the Center for
Substance Abuse Treatment NAC), and
the two SAMHSA Advisory Committees
(Advisory Committee for Women’s
Services, and the Tribal Technical
Advisory Committee).
The Councils were established to
advise the Secretary, Department of
Health and Human Services (HHS), the
Administrator, SAMHSA, and Center
Directors, concerning matters relating to
the activities carried out by and through
the Centers and the policies respecting
such activities.
Under Section 501 of the Public
Health Service Act, the Advisory
Committee for Women’s Services
(ACWS) is statutorily mandated to
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 78, Number 49 (Wednesday, March 13, 2013)]
[Notices]
[Pages 15960-15961]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05773]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information on the FY 2013-2018 Strategic Plan for
the Office of Disease Prevention
SUMMARY: The purpose of this Request for Information (RFI) is to seek
broad public input on the Fiscal Year (FY) 2013-2018 Strategic Plan for
the Office of Disease Prevention (ODP), National Institutes of Health
(NIH).
DATES: To ensure consideration, responses must be received by April 14,
2013.
ADDRESSES: Comments must be submitted electronically using the web-
based form available at https://prevention.nih.gov/aboutus/strategic_plan/rfi.aspx.
FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to Wilma
Peterman Cross, M.S.; Senior Public Health Advisor, Office of Disease
Prevention, National Institutes of Health; phone: 301-496-1508; email:
prevention@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The mission of ODP is to improve the public
health by increasing the scope, quality, dissemination, and impact of
prevention research supported by the NIH. ODP will fulfill this mission
by providing leadership for the development, coordination, and
implementation of prevention research in collaboration with the NIH
Institutes and Centers (ICs) and other partners. The Office is
responsible for advising the Director, NIH, regarding prevention
research issues, actions, and activities. The Office also provides
overall guidance to the ICs on biomedical programs that seek to improve
the nation's health through research, training, knowledge translation,
and public education as they relate to health promotion and disease
prevention.
Prevention research at the NIH encompasses research designed both
to promote health and to prevent the onset of disease, disorders, or
injuries and the progression of asymptomatic disease. Prevention
research targets biology and genetics, individual behavior, factors in
the social and physical environments, and health services; and it
informs and evaluates health-related policies and regulations.
Prevention research includes:
Identification and assessment of risk and protective
factors.
Screening and identification of individuals and groups at
risk.
Development and evaluation of interventions to reduce
risk.
Translation and dissemination of effective preventive
interventions into practice.
Development of research methods to support this work.
The Office was established in 1986 in response to a directive in
the Health Research Extension Act of 1985. With increased attention on
the application of prevention research nationally and the recent
reorganization of ODP, the Office has embarked on an extensive planning
process to develop a strategic plan for FY 2013-2018.
Information Requested
This RFI is intended to gather broad public input on the strategic
priorities to be included in the plan and other suggestions on how to
enhance the prevention research portfolio at the NIH. The ODP invites
input from prevention researchers in academia and industry; from health
care professionals, patient advocates and advocacy organizations,
scientific or professional organizations, federal agencies; and from
other interested members of the public. Organizations are strongly
encouraged to submit a single response that reflects the views of their
organization and membership as a whole.
Your perspectives can include, but are not limited to, the
following topics as they relate to the six draft strategic priorities
listed below:
Suggested changes, additions, or deletions to the list of
strategic priorities
Recommended measurable objectives associated with an
individual priority
Appropriate benchmarks for gauging progress toward each
recommended objective.
Strategic Priority #1: Systematically monitor NIH investments in
prevention research and the progress and results of that research.
Strategic Priority #2: Identify and promote prevention research
areas that deserve expanded effort and investment by the NIH.
Strategic Priority #3: Promote the use of the best available
methods in prevention research and support the development of new and
innovative approaches.
Strategic Priority #4: Encourage development of collaborative
prevention research projects and facilitate coordination of such
projects across the NIH and with other public and private entities.
Strategic Priority #5: Identify and promote the use of effective
evidence-based interventions.
Strategic Priority #6: Increase the visibility of prevention
research at the NIH and across the country.
In addition to the strategic priorities, the ODP welcomes
suggestions on how to enhance the prevention research portfolio at the
NIH:
1. Suggested changes to the approach used by the NIH to develop
funding opportunity announcements that could improve the quality of
prevention research supported by the NIH.
2. Suggested changes to the approach used by the NIH to review
applications that could improve the quality of prevention research
supported by the NIH.
3. Suggested changes to the approach used by the NIH in managing
funded projects that could improve the quality of prevention research
supported by the NIH.
How To Submit a Response
To ensure consideration, responses must be received by April 14,
2013, and should be submitted electronically using the web-based form
available at https://prevention.nih.gov/aboutus/strategic_plan/rfi.aspx. The web form will provide confirmation of response
[[Page 15961]]
submission, but respondents will not receive individualized feedback.
All respondents are encouraged to sign up for the ODP email list at
https://prevention-nih.org/subscribe to receive information related to
Office activities, including updates on the development and release of
the final strategic plan. Responses to this RFI are voluntary and may
be submitted anonymously. Please do not include any personally
identifiable or other information that you do not wish to make public.
Proprietary, classified, confidential, or sensitive information should
not be included in responses. Comments submitted will be compiled for
discussion and incorporated into the ODP strategic plan as appropriate.
Any personal identifiers (personal names, email addresses, etc.) will
be removed when responses are compiled. This RFI is for informational
and planning purposes only and is not a solicitation for applications
or an obligation on the part of the United States Government to provide
support for any ideas identified in response to it. Please note that
the U.S. Government will not pay for the preparation of any information
submitted or for use of that information.
Dated: February 5, 2013.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2013-05773 Filed 3-12-13; 8:45 am]
BILLING CODE 4140-01-P
